Marcelo Pasquini, M.D., M.S., and Alan Hutson, Ph.D.
Learn about adverse reactions to some cancer immunotherapies and immune-modulating drugs, and hear about the development of safety models to identify the risks and patterns of these reactions. Just register for the third course of the 2023 SITC-NCI Computational Immuno-Oncology Webinar Series.